AnaptysBio Inc buy Guggenheim
Start price
18.12.25
/
50%
€40.20
Target price
18.12.26
-
Performance (%)
-4.48%
Price
08.01.26
€37.40
Summary
This prediction is currently active. With a performance of -4.48%, the BUY prediction by Guggenheim is trending in the wrong direction. This prediction currently runs until 18.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| AnaptysBio Inc | -1.579% |
| iShares Core DAX® | 3.002% |
| iShares Nasdaq 100 | 2.966% |
| iShares Nikkei 225® | 5.606% |
| iShares S&P 500 | 2.312% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (NASDAQ:ANAB) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for ANAB provided by MarketBeat